Anubha Gupta

Statistics

Publications

Citations

280

H-Index

Active since

2007

Affiliations

GlaxoSmithKline (United States)(Current)

Age UK

University of Oxford

Anubha Gupta is an author at GlaxoSmithKline (United States) specializing in monoclonal antibody therapy, therapeutic monoclonal antibodies, and autoimmune rheumatic diseases.

Publications per year

2007–2023

Publications

In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids

Markus Fridén, Anubha Gupta, Madeleine Antonsson et al. · Drug Metabolism and Disposition · 2007 · 201 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

Christopher D. Buckley, Jesus Abraham Simón Campos, Brandon Becker et al. · The Lancet Rheumatology · 2020 · 44 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2)

Roy Fleischmann, Désirée van der Heijde, Vibeke Strand et al. · Annals of the Rheumatic Diseases · 2023 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

1–3 of 3